{"nctId":"NCT00708123","briefTitle":"In Situ Caries of Fluoride Toothpastes","startDateStruct":{"date":"2007-11"},"conditions":["Healthy Subjects","Partial Denture Wearers","Caries"],"count":60,"armGroups":[{"label":"Sodium Fluoride (NaF) toothpaste[1350 parts per million(ppm)F]","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sodium fluoride toothpaste"]},{"label":"NaF/Carbopol toothpaste (1400 ppm F)","type":"EXPERIMENTAL","interventionNames":["Drug: Sodium fluoride toothpaste"]},{"label":"NaMFP/NaF toothpaste (1450 ppm F)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sodium fluoride toothpaste"]},{"label":"NaF toothpaste (250 ppm F)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Sodium fluoride toothpaste"]},{"label":"Placebo toothpaste (0 ppm F)","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo toothpaste"]}],"interventions":[{"name":"Sodium fluoride toothpaste","otherNames":["Fluoride"]},{"name":"Placebo toothpaste","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria\n\n1. Consent: Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.\n2. Age:Aged between 18 and 78 years.\n3. Compliance:Understands and is willing, able and likely to comply with all study procedures and restrictions.\n4. General Health:Good general health with (in the opinion of the investigator) no clinically significant and/or relevant abnormalities of medical history or oral examination that could interfere with subject safety during the study period.\n5. Diagnosis: Oral - i. Currently living in the Indianapolis area which is a fluoridated community (1 ppm F). ii. Currently wearing a removable mandibular partial denture with sufficient room in the posterior buccal flange area to accommodate two enamel specimens (required dimensions 12 x 7 millimeters (mm). iii. Willing and capable of wearing their removable partial dentures 24 hours per day during each two week treatment period. iv.All restorations in a good state of repair.\n6. Salivary Flow:Have a salivary flow rate in the range of normal values (unstimulated whole saliva flow rate = 0.2 ml/minute; gum base stimulated whole saliva flow rate = 0.8 ml/minute).\n\nExclusion Criteria\n\n1. Pregnancy:Women who are known to be pregnant or who are intending to become pregnant over the duration of the study. No pregnancy test will be required.\n2. Breast-feeding:Women who are breast-feeding.\n3. Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.\n4. Clinical Study/Experimental Medication:Participation in another clinical study or receipt of an investigational drug within 30 days of the first treatment visit, with the exception of study T3157495 where the wash in period prior to treatment is sufficient.\n5. Antibiotics:Currently taking antibiotics or have taken antibiotics in the 2 weeks prior to the screening visit.\n6. Fluoride:Taking fluoride supplements for medical reasons.\n7. Dental Health: Current active caries or periodontal disease that may compromise the study or health of the subjects.\n8. Personnel: a) A member of the site study staff, b) An employee of the sponsor, c) Any employee of any toothpaste manufacturer or their spouse or family member.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"78 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Percentage Surface Microhardness Recovery (%SMHR) of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF) Compared to NaMFP/NaF Toothpaste (1450ppmF)","description":"%SMHR test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. %SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. %SMHR was calculated from indentation values of enamel specimens at baseline (B), after intra-oral exposure (R) and after in-vitro demineralization (D) using formula: \\[(D-R)/ (D-B)\\]\\*100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.54","spread":"1.72"},{"groupId":"OG001","value":"35.23","spread":"1.74"},{"groupId":"OG002","value":"29.57","spread":"1.72"}]}]}]},{"type":"SECONDARY","title":"Mean %SMHR of Enamel Specimens Exposed to NaF/Carbopol Toothpaste (1400 ppmF), NaF Toothpaste (1350ppmF), NaMFP/NaF Toothpaste (1450ppmF), NaF Toothpaste (250ppmF) and Placebo Toothpaste (0ppmF)","description":"%SMHR test was used to assess mineralization status of enamel specimens using a Wilson 2100 Hardness tester. %SMHR was determined by measuring the length of the indentations of enamel specimens. An increase in the indentation length compared to the baseline indicates softening while decrease in the indentation length represents rehardening of enamel surface. %SMHR was calculated from indentation values of enamel specimens at baseline (B), after intra-oral exposure (R) and after in-vitro demineralization (D) using formula: \\[(D-R)/ (D-B)\\]\\*100.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.54","spread":"1.72"},{"groupId":"OG001","value":"35.23","spread":"1.74"},{"groupId":"OG002","value":"24.98","spread":"1.72"},{"groupId":"OG003","value":"29.57","spread":"1.72"},{"groupId":"OG004","value":"22.05","spread":"1.73"}]}]}]},{"type":"SECONDARY","title":"Adjusted Mean Change From Baseline in Enamel Fluoride Uptake","description":"Enamel fluoride uptake was determined using the microdrill enamel biopsy technique. The amount of fluoride uptake by enamel was calculated based on the amount of fluoride (F) divided by the area of the enamel cores and expressed as ug F/cm2. The difference between treatments was calculated with respect to fluoride uptake by enamel.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1283.13","spread":"71.53"},{"groupId":"OG001","value":"1333.09","spread":"72.08"},{"groupId":"OG002","value":"680.20","spread":"71.48"},{"groupId":"OG003","value":"1086.39","spread":"71.42"},{"groupId":"OG004","value":"435.58","spread":"71.54"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":56},"commonTop":["Nasopharyngitis"]}}}